<DOC>
	<DOCNO>NCT03104569</DOCNO>
	<brief_summary>The purpose study determine effect normal temperature 37℃ non-ionic contrast agent act ERCP-related cholangeitis endoscopic retrograde cholangiopancreatography ( ERCP ) treatment hilar cholangiocarcinoma .</brief_summary>
	<brief_title>Effect 37℃ Non-ionic Contrast Agent During ERCP Procedure Hilar Cholangiocarcinoma</brief_title>
	<detailed_description>At present , common use contrast agent ERCP compose ionic non-ionic type , latter 's advantage lie slight toxic-and-side effect favorable security . When heat 37℃ , 20 ℃ contrast agent would dilute 50 % consistency , short time period intravascular intracavitary stay would add less cell damage . And application heat non-ionic contrast agent could find compute tomography angiography ( CTA ) , hysterosalpingography ( HSG ) cystourethrography , consequently patient intervention heat non-ionic contrast agent felt comfortable few adverse reaction could observe . Nevertheless , heat contrast agent rarely report act ERCP . It 's theoretically possible heat-reduced low mucosity could help contrast agent drainage , incidence cholangeitis could control .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Klatskin Tumor</mesh_term>
	<criteria>Type Ⅰ、Ⅱ、Ⅲ、Ⅳ Hilar Cholangiocarcinoma ; Age : 18~90 year old ; Underwent diagnostic therapeutic ERCP ; Coagulation dysfunction ( INR＞1.3 ) or/and low peripheral blood platelet count （PLT &lt; 50x10^9/L） ; Preoperative acute cholangitis ; Preoperative acute pancreatitis ; Preoperative hemobilia hemorrhage digestive tract ; Preoperative liver failure ; Combined Mirizzi syndrome intrahepatic bile duct stone ; Preoperative malignant tumor biliary system carcinoma head pancreas , gallbladder carcinoma ; Biliaryduodenal fistula confirm ERCP ; A history reconstructive surgery upper digestive tract except Billroth Ⅰand history cholangioenterostomy include cholangiojejunostomy side side anastomosis bile duct duodenum ; Previous ERCP ; Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>ERCP</keyword>
	<keyword>Contrast agent</keyword>
	<keyword>Hilar cholangiocarcinoma</keyword>
	<keyword>Cholangitis</keyword>
	<keyword>Nonionic</keyword>
</DOC>